In:
Molecular Nutrition & Food Research, Wiley, Vol. 63, No. 11 ( 2019-06)
Abstract:
High‐salt diets (HSDs) are widely considered to cause health problems such as gut microecological imbalances, constipation, and hypertension. This study explores how lactulose as a safe molecule can stimulate bodily responses to alleviate salt‐sensitive hypertension by regulating the gut microbiotas of HSD‐fed mice. Methods and results After 4 weeks, the blood pressures of mice fed a high‐salt plus lactulose diet (HSLD) are significantly lower than those of the HSD‐fed mice. The HSD increases the abundances of Alistipes and Ruminococcaceae_UCG_009 and reduced the abundance of Lactobacillus in the gut, while lactulose supplementation increases the abundances of Bifidobacterium , Alloprevotella , and Subdoligranulum . Fecal metabolic profiling shows significant increases in metabolites involved in ATP‐binding cassette transporter pathways, and tryptophan metabolism is significantly reduced in the HSLD group compared with the HSD group. Lactulose maintains the intestinal microenvironmental health in the HSD‐fed mice by improving glycolipid metabolism, decreasing the small intestinal interleukin‐17a ( IL‐17a ) and interleukin‐22 ( IL‐22 ) mRNA levels and serum IL‐17a and IL‐22 levels, relieving constipation, increasing fecal sodium, and reducing intestinal permeability. Conclusion Lactulose negates salt‐sensitive hypertension. Regulating the gut microbiota is a potential treatment for salt‐sensitive hypertension.
Type of Medium:
Online Resource
ISSN:
1613-4125
,
1613-4133
DOI:
10.1002/mnfr.201800941
Language:
English
Publisher:
Wiley
Publication Date:
2019
detail.hit.zdb_id:
2160372-8
SSG:
12
